Latest filing published 01 May 2026 for Avalyn Pharma Inc..
Insider track record
No signal scores available.
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.: trading record in brief
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is a declared insider at 6 companies; the most frequent names are MBX Biosciences, Inc., Avalyn Pharma Inc. and CARGO Therapeutics, Inc. Between 19 September 2023 and 1 May 2026, the trades on record add up to 7 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 1 May 2026, reports a transaction in Avalyn Pharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,275,486 sharesCommon StockSEC:0001193125-26-201863:0
- 1,857,699 sharesCommon StockSEC:0000950170-25-012574:0
- 894,733 sharesCommon StockSEC:0000950170-24-114802:0
- 1,386,335 sharesCommon StockSEC:0000950170-24-107489:0
- 737,000 sharesCommon StockSEC:0000950170-23-064519:0
- 1,557,846 sharesCommon StockSEC:0000950170-23-048874:0
6 of 6 declarations